Antimicrobial Susceptibility Testing Market - 2026-2033

April 2026 | 63 pages | ID: AD9E17C8248EEN
DataM Intelligence

US$ 3,400.00 US$ 4,350.00 -22 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Antimicrobial Susceptibility Testing Marketis is growing with a CAGR of 8.50% during the forecast period 2026-2035.

The Antimicrobial Susceptibility Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Antimicrobial Susceptibility Testing Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type
  • Manual Antimicrobial Susceptibility Testing Products*
    • Susceptibility Testing Disks
    • MIC Strips
    • Susceptibility Plates
  • Automated Laboratory Instruments
  • Consumables
By Method
  • Broth Dilution Method*
  • Rapid Automated Method
  • Disk Diffusion Method
  • Gradient Diffusion Method
  • Molecular Testing Method
By Test Type
  • Antibacterial*
  • Antifungal
  • Antiparasitics
  • Others
By End User
  • Clinical Diagnosis*
  • Drug Discovery and Development
  • Others
  • Diagnostic Centers and Hospitals*
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Research and Academic Institutes
Regional Analysis for Antimicrobial Susceptibility Testing Market:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global Antimicrobial Susceptibility Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Prevalence of Infectious Diseases
    4.1.1.2. Technological Advancements
  4.1.2. Restraints:
  4.1.3. Strict Regulatory Procedures
  4.1.4. Opportunity
  4.1.5. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis

6. BY PRODUCT TYPE

6.1. Introduction
  6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  6.1.2. Market Attractiveness Index, By Product Type
6.2. Manual Antimicrobial Susceptibility Testing Products*
  6.2.1. Introduction
  6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2023-2030
  6.2.3. Susceptibility Testing Disks
  6.2.4. MIC Strips
  6.2.5. Susceptibility Plates
6.3. Automated Laboratory Instruments
6.4. Consumables

7. BY METHOD

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  7.1.2. Market Attractiveness Index, By Method
7.2. Broth Dilution Method*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2023-2030
7.3. Rapid Automated Method
7.4. Disk Diffusion Method
7.5. Gradient Diffusion Method
7.6. Molecular Testing Method

8. BY TEST TYPE

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  8.1.2. Market Attractiveness Index, By Test Type
8.2. Antibacterial*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2023-2030
8.3. Antifungal
8.4. Antiparasitics
8.5. Others

9. BY APPLICATION

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  9.1.2. Market Attractiveness Index, By Application
9.2. Clinical Diagnosis*
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2023-2030
9.3. Drug Discovery and Development
9.4. Others

10. BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  10.1.2. Market Attractiveness Index, By End User
10.2. Diagnostic Centers and Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2023-2030
10.3. Pharmaceutical and Biotechnology Companies
10.4. Contract Research Organizations (CROs)
10.5. Research and Academic Institutes

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2023-2030, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  11.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.2.8.1. The U.S.
    11.2.8.2. Canada
    11.2.8.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  11.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.3.8.1. Germany
    11.3.8.2. U.K.
    11.3.8.3. France
    11.3.8.4. Italy
    11.3.8.5. Spain
    11.3.8.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  11.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.8.1. Brazil
    11.4.8.2. Argentina
    11.4.8.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  11.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.8.1. China
    11.5.8.2. India
    11.5.8.3. Japan
    11.5.8.4. Australia
    11.5.8.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking

13. COMPANY PROFILES

13.1. bioM?rieux S.A.*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Danaher Corporation
13.3. Becton, Dickinson and Company
13.4. Thermo Fisher Scientific Inc.
13.5. Bio-Rad Laboratories Inc.
13.6. Merck Group
13.7. HiMedia Laboratories
13.8. Alifax Holding S.p.A.
13.9. Creative Diagnostics
13.10. Synbiosis (*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Services
14.3. Contact Us


More Publications